TFDA — Drug Supply Information Platform (Taiwan) (TFDA)

TFDA — Drug Supply Information Platform (Taiwan) is the official source of medicine shortage information for Taiwan (Asia Pacific). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.fda.gov.tw

Country

Taiwan

Notices tracked by Mederti

257

Last checked

6 Nov 2026

Latest notices from TFDA

• Dacarbazine — active, medium, since 29 Oct 2026 (source)
• Amiodarone — active, medium, since 29 Oct 2026 (source)
• Lidocaine — active, medium, since 29 Oct 2026 (source)
• Idarubicin Hcl — active, medium, since 27 Oct 2026 (source)
• Amlodipine Besylate; Valsartan — active, medium, since 21 Oct 2026 (source)
• Valsartan; Amlodipine Besylate — active, medium, since 21 Oct 2026 (source)
• Cladribine — active, medium, since 17 Oct 2026 (source)
• Epirubicin — active, medium, since 15 Oct 2026 (source)
• Codeine Phosphate; Terpin Hydrate — active, medium, since 7 Oct 2026 (source)
• Amikacin — active, medium, since 5 Oct 2026 (source)
• Epinephrine Bitartrate; Articaine Hydrochloride — active, medium, since 18 Sept 2026 (source)
• Heparin Sodium — active, medium, since 18 Sept 2026 (source)
• Articaine Hydrochloride; Epinephrine Bitartrate — active, medium, since 18 Sept 2026 (source)
• Calcium Chloride Dihydrate; Sodium Chloride; Potassium Chloride; Magnesium Chloride Hexahydrate — active, medium, since 16 Sept 2026 (source)
• Fibrinogen Human — active, medium, since 1 Sept 2026 (source)

Mederti is not affiliated with or endorsed by TFDA — Drug Supply Information Platform (Taiwan). All notices remain the property of their publisher and are linked to the original source.